BIAL
Porto, Portugal · Biopharma, Biotechnology, Health Care
BIAL is a hundred-year-old innovation-driven biopharmaceutical company focused on neurosciences and rare diseases. It is dedicated to the development of novel therapies that aim to improve patient care, particularly in neurodegenerative diseases. With a strong emphasis on research and development, BIAL seeks to create transformative value for those affected by such conditions. The company is commi
Key facts
- Headquarters
- Porto, Portugal
- Employees
- 930
- Industries
- Biopharma, Biotechnology, Health Care
- Website
- bial.com
- Company page
Recent activity at BIAL
Leadership
- George Fanthome, Chief Technology Officer
- Satyaki Raghunath, Chief Operating Officer
- Hari Marar, Chief Executive Officer
- Shalini Rao, Established Brands and Driven Growth
Verified email and direct lines for BIAL’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
BIAL in the news
- Bial Announces Completion of Phase 2b ACTIVATE Study with BIA 28-6156 in GBA1-Associated Parkinson’s - Business Wire (May 26, 2026)
- Bial drops development on new Parkinson drug - Essential Business (Jun 10, 2026)
- Bial Reports Topline Results From ACTIVATE Phase 2b Study in GBA‑Associated Parkinson’s - Business Wire (Jun 09, 2026)
- Bial Ends Development Of Parkinson’s Disease Drug After Phase IIb Fail - insights.citeline.com (Jun 09, 2026)
- Bial's Pariceract Fails in GBA Parkinson's Trial - AllSci (Jun 09, 2026)
- Bial Showcases Parkinson’s Research at MDS 2026 - Business Wire (Oct 05, 2026)
- Review of New Evidence for GBA1 Parkinson's Disease Offers Treatment Insights - Neurology Today (Aug 20, 2026)
- BIAL Acquires Parkinson’s Treatment LTI-291, Opens US Research Center - Parkinson's News Today (Oct 06, 2020)
Companies similar to BIAL
- Supernus Pharmaceuticals · Biopharma, Biotechnology, Health Care, Therapeutics
- Daiichi Sankyo · Biopharma, Biotechnology, Health Care, Therapeutics
- Apellis Pharmaceuticals · Biopharma, Biotechnology, Health Care, Therapeutics
- Madrigal Pharmaceuticals · Biopharma, Biotechnology, Health Care, Therapeutics
- Arcus Biosciences · Biopharma, Biotechnology, Health Care, Therapeutics
About BIAL: questions and answers
What does BIAL do?
BIAL is a hundred-year-old innovation-driven biopharmaceutical company focused on neurosciences and rare diseases. It is dedicated to the development of novel therapies that aim to improve patient care, particularly in neurodegenerative diseases. With a strong emphasis on research and development, BIAL seeks to create transformative value for those affected by such conditions. The company is commi
Where is BIAL headquartered?
BIAL is headquartered in Porto, Portugal.
How many employees does BIAL have?
BIAL has about 930 employees.
Who leads BIAL?
Hari Marar is a Chief Executive Officer at BIAL.
What is the latest news on BIAL?
On Jan 07, 2025, BIAL Reports Successful First Patient Completion in Phase 2 Study of BIA 28-6156 for GBA1 Parkinson's Disease Treatment
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy